IoT Analytics: A Growth Driver for the High Tech Industry

whitePaper | January 1, 2020

With over 2,800 campaigns each year delivered through a team of 300+ digital, data, and technology specialists, Deck 7 is a first resource for B2B demand generation services for marketers worldwide. Clients leverage Deck 7’s multichannel content marketing services and Media 7’s network of 30+ online publications for content syndication to engage over 95 million buyers across 16 industries and 120+ countries.

whitePaper | August 25, 2022

Most organizations realize data governance is necessary - if not indispensable - for mitigating data risk while sustaining its longterm value. However, there’s still a fair amount of ambiguity around what exactly data governance is and how to best implement it. By definition, data governance is an enterprise-wide initiative for formalizing the processes, people, and protocols for using data. It reduces risk while increasing data’s ultimate value: consistent reusability for achieving mission critical objectives. Data governance is a strategic approach for creating unassailable trust in data throughout the enterprise.

whitePaper | April 7, 2022

This white paper was created to outline best-practices for measuring, reporting, and building a constant stream of key performance indicators related to your physician network.

whitePaper | June 2, 2022

Data lakeshold enormous promise in supporting modern enterprise data architectures. Their ability to store a full variety of data types and handle ever-larger data volumes generated at high velocity have contributed to their widespread adoption.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.

whitePaper | February 8, 2023

For centuries, patients have sought medical help for their ailments. Just as in the past, however, there are still many illnesses – both wellknown, widespread diseases and rare conditions – that initially cause few or inconclusive symptoms, and many patients leave the doctor’s office with an incorrect diagnosis. In addition, diseases may progress slowly or quickly depending on the individual.